HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-JUN-16 5KKT TITLE ROCK 1 BOUND TO AZAINDOLE THIAZOLE PIPERAZINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RHO-ASSOCIATED PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RENAL CARCINOMA ANTIGEN NY-REN-35, RHO-ASSOCIATED,COILED- COMPND 5 COIL-CONTAINING PROTEIN KINASE 1, COILED-COIL-CONTAINING PROTEIN COMPND 6 KINASE I, ROCK-I, P160 ROCK-1, P160ROCK; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ROCK1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BTI-TN-5B1-4 KEYWDS KINASE, INHIBITOR, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.D.JACOBS REVDAT 4 27-SEP-23 5KKT 1 REMARK REVDAT 3 11-JUL-18 5KKT 1 TITLE JRNL REVDAT 2 22-NOV-17 5KKT 1 REMARK REVDAT 1 28-JUN-17 5KKT 0 JRNL AUTH U.K.BANDARAGE,J.CAO,J.H.COME,J.J.COURT,H.GAO,M.D.JACOBS, JRNL AUTH 2 C.MARHEFKA,S.NANTHAKUMAR,J.GREEN JRNL TITL ROCK INHIBITORS 3: DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY JRNL TITL 2 RELATIONSHIPS OF 7-AZAINDOLE-BASED RHO KINASE (ROCK) JRNL TITL 3 INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. 2018 JRNL REFN ESSN 1464-3405 JRNL DOI 10.1016/J.BMCL.2018.06.040 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 42505 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 2076 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.84 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3160 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3016 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.56 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6357 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 192 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 88.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.60110 REMARK 3 B22 (A**2) : -2.60110 REMARK 3 B33 (A**2) : 5.20230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.390 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.393 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.258 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.400 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.262 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6588 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8902 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2298 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 174 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 945 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6588 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 800 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7691 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.04 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 52.3938 110.0032 27.4936 REMARK 3 T TENSOR REMARK 3 T11: -0.0694 T22: -0.0423 REMARK 3 T33: -0.3122 T12: 0.1539 REMARK 3 T13: 0.0660 T23: 0.0254 REMARK 3 L TENSOR REMARK 3 L11: 3.1271 L22: 1.0541 REMARK 3 L33: 1.4994 L12: -0.9971 REMARK 3 L13: 0.6033 L23: -0.2367 REMARK 3 S TENSOR REMARK 3 S11: -0.1091 S12: -0.4119 S13: -0.1320 REMARK 3 S21: -0.0197 S22: 0.1556 S23: -0.0122 REMARK 3 S31: -0.2588 S32: -0.2666 S33: -0.0465 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 0.0708 129.2160 22.6605 REMARK 3 T TENSOR REMARK 3 T11: 0.0602 T22: -0.1026 REMARK 3 T33: -0.2707 T12: 0.2054 REMARK 3 T13: 0.0536 T23: 0.0055 REMARK 3 L TENSOR REMARK 3 L11: 3.2513 L22: 0.7635 REMARK 3 L33: 0.7063 L12: -1.0145 REMARK 3 L13: -0.4754 L23: 0.2061 REMARK 3 S TENSOR REMARK 3 S11: -0.0621 S12: -0.2634 S13: 0.0402 REMARK 3 S21: -0.0583 S22: 0.1195 S23: 0.0233 REMARK 3 S31: 0.2283 S32: 0.3438 S33: -0.0574 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KKT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000222396. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED DUAL REMARK 200 CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK 8.0SSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42532 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 29.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 6.570 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.47 REMARK 200 R MERGE FOR SHELL (I) : 0.34400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER-TNT REMARK 200 STARTING MODEL: PDB ENTRY 2ETR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.45 MM PROTEIN, 5% PEG3350, 100 MM REMARK 280 MES, 50 MM CALCIUM CHLORIDE, 10 MM DTT, PH 5.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.18667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 60.37333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 60.37333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.18667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 SER A 2 REMARK 465 LEU A 3 REMARK 465 HIS A 4 REMARK 465 MET A 5 REMARK 465 ARG A 115 REMARK 465 SER A 116 REMARK 465 ASP A 117 REMARK 465 SER A 118 REMARK 465 GLU A 372 REMARK 465 GLU A 373 REMARK 465 ASP A 374 REMARK 465 LYS A 375 REMARK 465 GLY A 376 REMARK 465 GLU A 377 REMARK 465 GLU A 378 REMARK 465 LEU A 406 REMARK 465 SER A 407 REMARK 465 SER A 408 REMARK 465 ALA A 409 REMARK 465 ASN A 410 REMARK 465 PRO A 411 REMARK 465 ASN A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 ARG A 415 REMARK 465 GLY B 1 REMARK 465 SER B 2 REMARK 465 LEU B 3 REMARK 465 HIS B 4 REMARK 465 GLU B 372 REMARK 465 GLU B 373 REMARK 465 ASP B 374 REMARK 465 LYS B 375 REMARK 465 ARG B 403 REMARK 465 ARG B 404 REMARK 465 TYR B 405 REMARK 465 LEU B 406 REMARK 465 SER B 407 REMARK 465 SER B 408 REMARK 465 ALA B 409 REMARK 465 ASN B 410 REMARK 465 PRO B 411 REMARK 465 ASN B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 ARG B 415 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 6 OG REMARK 470 LYS A 114 CG CD CE NZ REMARK 470 TYR A 287 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 MET B 5 CG SD CE REMARK 470 ASP B 302 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 197 -4.25 71.19 REMARK 500 ASP A 216 79.42 50.52 REMARK 500 GLN A 249 -158.97 -140.04 REMARK 500 ASP A 252 -121.80 -79.26 REMARK 500 ASN A 303 7.41 -51.44 REMARK 500 TYR A 400 -64.96 -161.14 REMARK 500 SER B 116 -154.89 52.68 REMARK 500 ALA B 119 -3.59 -140.21 REMARK 500 ARG B 197 -14.73 71.48 REMARK 500 ASP B 216 80.15 50.10 REMARK 500 THR B 237 110.85 74.12 REMARK 500 ASN B 303 -3.81 -40.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6U2 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6U2 B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KKS RELATED DB: PDB DBREF 5KKT A 6 415 UNP Q13464 ROCK1_HUMAN 6 415 DBREF 5KKT B 6 415 UNP Q13464 ROCK1_HUMAN 6 415 SEQADV 5KKT GLY A 1 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT SER A 2 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT LEU A 3 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT HIS A 4 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT MET A 5 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT GLY B 1 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT SER B 2 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT LEU B 3 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT HIS B 4 UNP Q13464 CLONING ARTIFACT SEQADV 5KKT MET B 5 UNP Q13464 CLONING ARTIFACT SEQRES 1 A 415 GLY SER LEU HIS MET SER PHE GLU THR ARG PHE GLU LYS SEQRES 2 A 415 MET ASP ASN LEU LEU ARG ASP PRO LYS SER GLU VAL ASN SEQRES 3 A 415 SER ASP CYS LEU LEU ASP GLY LEU ASP ALA LEU VAL TYR SEQRES 4 A 415 ASP LEU ASP PHE PRO ALA LEU ARG LYS ASN LYS ASN ILE SEQRES 5 A 415 ASP ASN PHE LEU SER ARG TYR LYS ASP THR ILE ASN LYS SEQRES 6 A 415 ILE ARG ASP LEU ARG MET LYS ALA GLU ASP TYR GLU VAL SEQRES 7 A 415 VAL LYS VAL ILE GLY ARG GLY ALA PHE GLY GLU VAL GLN SEQRES 8 A 415 LEU VAL ARG HIS LYS SER THR ARG LYS VAL TYR ALA MET SEQRES 9 A 415 LYS LEU LEU SER LYS PHE GLU MET ILE LYS ARG SER ASP SEQRES 10 A 415 SER ALA PHE PHE TRP GLU GLU ARG ASP ILE MET ALA PHE SEQRES 11 A 415 ALA ASN SER PRO TRP VAL VAL GLN LEU PHE TYR ALA PHE SEQRES 12 A 415 GLN ASP ASP ARG TYR LEU TYR MET VAL MET GLU TYR MET SEQRES 13 A 415 PRO GLY GLY ASP LEU VAL ASN LEU MET SER ASN TYR ASP SEQRES 14 A 415 VAL PRO GLU LYS TRP ALA ARG PHE TYR THR ALA GLU VAL SEQRES 15 A 415 VAL LEU ALA LEU ASP ALA ILE HIS SER MET GLY PHE ILE SEQRES 16 A 415 HIS ARG ASP VAL LYS PRO ASP ASN MET LEU LEU ASP LYS SEQRES 17 A 415 SER GLY HIS LEU LYS LEU ALA ASP PHE GLY THR CYS MET SEQRES 18 A 415 LYS MET ASN LYS GLU GLY MET VAL ARG CYS ASP THR ALA SEQRES 19 A 415 VAL GLY THR PRO ASP TYR ILE SER PRO GLU VAL LEU LYS SEQRES 20 A 415 SER GLN GLY GLY ASP GLY TYR TYR GLY ARG GLU CYS ASP SEQRES 21 A 415 TRP TRP SER VAL GLY VAL PHE LEU TYR GLU MET LEU VAL SEQRES 22 A 415 GLY ASP THR PRO PHE TYR ALA ASP SER LEU VAL GLY THR SEQRES 23 A 415 TYR SER LYS ILE MET ASN HIS LYS ASN SER LEU THR PHE SEQRES 24 A 415 PRO ASP ASP ASN ASP ILE SER LYS GLU ALA LYS ASN LEU SEQRES 25 A 415 ILE CYS ALA PHE LEU THR ASP ARG GLU VAL ARG LEU GLY SEQRES 26 A 415 ARG ASN GLY VAL GLU GLU ILE LYS ARG HIS LEU PHE PHE SEQRES 27 A 415 LYS ASN ASP GLN TRP ALA TRP GLU THR LEU ARG ASP THR SEQRES 28 A 415 VAL ALA PRO VAL VAL PRO ASP LEU SER SER ASP ILE ASP SEQRES 29 A 415 THR SER ASN PHE ASP ASP LEU GLU GLU ASP LYS GLY GLU SEQRES 30 A 415 GLU GLU THR PHE PRO ILE PRO LYS ALA PHE VAL GLY ASN SEQRES 31 A 415 GLN LEU PRO PHE VAL GLY PHE THR TYR TYR SER ASN ARG SEQRES 32 A 415 ARG TYR LEU SER SER ALA ASN PRO ASN ASP ASN ARG SEQRES 1 B 415 GLY SER LEU HIS MET SER PHE GLU THR ARG PHE GLU LYS SEQRES 2 B 415 MET ASP ASN LEU LEU ARG ASP PRO LYS SER GLU VAL ASN SEQRES 3 B 415 SER ASP CYS LEU LEU ASP GLY LEU ASP ALA LEU VAL TYR SEQRES 4 B 415 ASP LEU ASP PHE PRO ALA LEU ARG LYS ASN LYS ASN ILE SEQRES 5 B 415 ASP ASN PHE LEU SER ARG TYR LYS ASP THR ILE ASN LYS SEQRES 6 B 415 ILE ARG ASP LEU ARG MET LYS ALA GLU ASP TYR GLU VAL SEQRES 7 B 415 VAL LYS VAL ILE GLY ARG GLY ALA PHE GLY GLU VAL GLN SEQRES 8 B 415 LEU VAL ARG HIS LYS SER THR ARG LYS VAL TYR ALA MET SEQRES 9 B 415 LYS LEU LEU SER LYS PHE GLU MET ILE LYS ARG SER ASP SEQRES 10 B 415 SER ALA PHE PHE TRP GLU GLU ARG ASP ILE MET ALA PHE SEQRES 11 B 415 ALA ASN SER PRO TRP VAL VAL GLN LEU PHE TYR ALA PHE SEQRES 12 B 415 GLN ASP ASP ARG TYR LEU TYR MET VAL MET GLU TYR MET SEQRES 13 B 415 PRO GLY GLY ASP LEU VAL ASN LEU MET SER ASN TYR ASP SEQRES 14 B 415 VAL PRO GLU LYS TRP ALA ARG PHE TYR THR ALA GLU VAL SEQRES 15 B 415 VAL LEU ALA LEU ASP ALA ILE HIS SER MET GLY PHE ILE SEQRES 16 B 415 HIS ARG ASP VAL LYS PRO ASP ASN MET LEU LEU ASP LYS SEQRES 17 B 415 SER GLY HIS LEU LYS LEU ALA ASP PHE GLY THR CYS MET SEQRES 18 B 415 LYS MET ASN LYS GLU GLY MET VAL ARG CYS ASP THR ALA SEQRES 19 B 415 VAL GLY THR PRO ASP TYR ILE SER PRO GLU VAL LEU LYS SEQRES 20 B 415 SER GLN GLY GLY ASP GLY TYR TYR GLY ARG GLU CYS ASP SEQRES 21 B 415 TRP TRP SER VAL GLY VAL PHE LEU TYR GLU MET LEU VAL SEQRES 22 B 415 GLY ASP THR PRO PHE TYR ALA ASP SER LEU VAL GLY THR SEQRES 23 B 415 TYR SER LYS ILE MET ASN HIS LYS ASN SER LEU THR PHE SEQRES 24 B 415 PRO ASP ASP ASN ASP ILE SER LYS GLU ALA LYS ASN LEU SEQRES 25 B 415 ILE CYS ALA PHE LEU THR ASP ARG GLU VAL ARG LEU GLY SEQRES 26 B 415 ARG ASN GLY VAL GLU GLU ILE LYS ARG HIS LEU PHE PHE SEQRES 27 B 415 LYS ASN ASP GLN TRP ALA TRP GLU THR LEU ARG ASP THR SEQRES 28 B 415 VAL ALA PRO VAL VAL PRO ASP LEU SER SER ASP ILE ASP SEQRES 29 B 415 THR SER ASN PHE ASP ASP LEU GLU GLU ASP LYS GLY GLU SEQRES 30 B 415 GLU GLU THR PHE PRO ILE PRO LYS ALA PHE VAL GLY ASN SEQRES 31 B 415 GLN LEU PRO PHE VAL GLY PHE THR TYR TYR SER ASN ARG SEQRES 32 B 415 ARG TYR LEU SER SER ALA ASN PRO ASN ASP ASN ARG HET 6U2 A 501 36 HET 6U2 B 501 36 HETNAM 6U2 2-[3-[3-(4-METHYLPIPERAZIN-1-YL)PROPOXY]PHENYL]-~{N}- HETNAM 2 6U2 [4-(1~{H}-PYRROLO[2,3-B]PYRIDIN-3-YL)-1,3-THIAZOL-2- HETNAM 3 6U2 YL]ETHANAMIDE FORMUL 3 6U2 2(C26 H30 N6 O2 S) FORMUL 5 HOH *192(H2 O) HELIX 1 AA1 SER A 6 ASP A 20 1 15 HELIX 2 AA2 ASN A 26 ASP A 42 1 17 HELIX 3 AA3 ASN A 49 ARG A 70 1 22 HELIX 4 AA4 LYS A 72 GLU A 74 5 3 HELIX 5 AA5 LYS A 109 LYS A 114 1 6 HELIX 6 AA6 PHE A 120 ALA A 131 1 12 HELIX 7 AA7 LEU A 161 TYR A 168 1 8 HELIX 8 AA8 PRO A 171 MET A 192 1 22 HELIX 9 AA9 LYS A 200 ASP A 202 5 3 HELIX 10 AB1 SER A 242 SER A 248 1 7 HELIX 11 AB2 ARG A 257 GLY A 274 1 18 HELIX 12 AB3 SER A 282 ASN A 292 1 11 HELIX 13 AB4 ASN A 292 LEU A 297 1 6 HELIX 14 AB5 SER A 306 LEU A 317 1 12 HELIX 15 AB6 ASP A 319 ARG A 323 5 5 HELIX 16 AB7 VAL A 329 ARG A 334 1 6 HELIX 17 AB8 HIS A 335 LYS A 339 5 5 HELIX 18 AB9 THR A 347 THR A 351 5 5 HELIX 19 AC1 GLN A 391 VAL A 395 5 5 HELIX 20 AC2 SER B 6 ASP B 20 1 15 HELIX 21 AC3 ASN B 26 ASP B 42 1 17 HELIX 22 AC4 ASN B 49 ARG B 70 1 22 HELIX 23 AC5 LYS B 72 GLU B 74 5 3 HELIX 24 AC6 LYS B 109 ARG B 115 1 7 HELIX 25 AC7 PHE B 120 ALA B 131 1 12 HELIX 26 AC8 LEU B 161 TYR B 168 1 8 HELIX 27 AC9 PRO B 171 MET B 192 1 22 HELIX 28 AD1 LYS B 200 ASP B 202 5 3 HELIX 29 AD2 SER B 242 SER B 248 1 7 HELIX 30 AD3 ARG B 257 GLY B 274 1 18 HELIX 31 AD4 SER B 282 ASN B 292 1 11 HELIX 32 AD5 ASN B 292 LEU B 297 1 6 HELIX 33 AD6 SER B 306 LEU B 317 1 12 HELIX 34 AD7 ASP B 319 ARG B 323 5 5 HELIX 35 AD8 VAL B 329 ARG B 334 1 6 HELIX 36 AD9 HIS B 335 LYS B 339 5 5 HELIX 37 AE1 THR B 347 THR B 351 5 5 HELIX 38 AE2 GLN B 391 VAL B 395 5 5 SHEET 1 AA1 5 TYR A 76 GLY A 85 0 SHEET 2 AA1 5 GLY A 88 HIS A 95 -1 O ARG A 94 N GLU A 77 SHEET 3 AA1 5 VAL A 101 SER A 108 -1 O TYR A 102 N VAL A 93 SHEET 4 AA1 5 TYR A 148 MET A 153 -1 O MET A 153 N ALA A 103 SHEET 5 AA1 5 LEU A 139 GLN A 144 -1 N TYR A 141 O VAL A 152 SHEET 1 AA2 3 GLY A 159 ASP A 160 0 SHEET 2 AA2 3 MET A 204 LEU A 206 -1 O LEU A 206 N GLY A 159 SHEET 3 AA2 3 LEU A 212 LEU A 214 -1 O LYS A 213 N LEU A 205 SHEET 1 AA3 2 PHE A 194 ILE A 195 0 SHEET 2 AA3 2 MET A 221 LYS A 222 -1 O MET A 221 N ILE A 195 SHEET 1 AA4 2 MET A 228 ARG A 230 0 SHEET 2 AA4 2 TYR A 254 GLY A 256 -1 O TYR A 255 N VAL A 229 SHEET 1 AA5 6 TYR B 76 GLY B 85 0 SHEET 2 AA5 6 GLY B 88 HIS B 95 -1 O ARG B 94 N GLU B 77 SHEET 3 AA5 6 VAL B 101 SER B 108 -1 O TYR B 102 N VAL B 93 SHEET 4 AA5 6 TYR B 148 MET B 153 -1 O MET B 153 N ALA B 103 SHEET 5 AA5 6 LEU B 139 GLN B 144 -1 N TYR B 141 O VAL B 152 SHEET 6 AA5 6 TYR B 399 TYR B 400 -1 O TYR B 399 N ALA B 142 SHEET 1 AA6 3 GLY B 159 ASP B 160 0 SHEET 2 AA6 3 MET B 204 LEU B 206 -1 O LEU B 206 N GLY B 159 SHEET 3 AA6 3 LEU B 212 LEU B 214 -1 O LYS B 213 N LEU B 205 SHEET 1 AA7 2 PHE B 194 ILE B 195 0 SHEET 2 AA7 2 MET B 221 LYS B 222 -1 O MET B 221 N ILE B 195 SHEET 1 AA8 2 MET B 228 ARG B 230 0 SHEET 2 AA8 2 TYR B 254 GLY B 256 -1 O TYR B 255 N VAL B 229 SITE 1 AC1 18 ILE A 82 PHE A 87 GLY A 88 GLU A 89 SITE 2 AC1 18 VAL A 90 ALA A 103 LYS A 105 LEU A 107 SITE 3 AC1 18 PHE A 120 VAL A 137 MET A 153 GLU A 154 SITE 4 AC1 18 MET A 156 LEU A 205 ALA A 215 ASP A 216 SITE 5 AC1 18 GLY A 218 PHE A 368 SITE 1 AC2 20 ILE B 82 GLY B 85 PHE B 87 GLY B 88 SITE 2 AC2 20 GLU B 89 VAL B 90 ALA B 103 LYS B 105 SITE 3 AC2 20 LEU B 107 ASP B 117 PHE B 120 VAL B 137 SITE 4 AC2 20 MET B 153 GLU B 154 TYR B 155 MET B 156 SITE 5 AC2 20 LEU B 205 ASP B 216 GLY B 218 PHE B 368 CRYST1 182.910 182.910 90.560 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005467 0.003156 0.000000 0.00000 SCALE2 0.000000 0.006313 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011042 0.00000